Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.54 Million ≈ $3.88 Million USD) by net assets (CN¥1.69 Billion ≈ $246.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Shaanxi Panlong Pharmaceutical Group Lim for a breakdown of total debt and financial obligations.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Medy-Tox Inc KQ:086900	0.041x
Shenzhen Ridge Engineering Consulting Co. Ltd. SHE:300977	N/A
Stor-Age Property REIT Ltd JSE:SSS	0.039x
Marimekko Oyj HE:MEKKO	0.170x
Heidelberger Druckmaschinen Aktiengesellschaft F:HDD	-0.009x
Guangdong Wanlima Industry Co Ltd SHE:300591	0.059x
LX Holdings Corp KO:383800	0.001x
Kis Wire KO:002240	0.016x

Annual Cash Flow Conversion Efficiency for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2024)

The table below shows the annual cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see 002864 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.64 Billion ≈ $239.57 Million	CN¥156.59 Million ≈ $22.91 Million	0.096x	+42.60%
2023-12-31	CN¥1.55 Billion ≈ $227.00 Million	CN¥104.05 Million ≈ $15.23 Million	0.067x	-49.30%
2022-12-31	CN¥947.60 Million ≈ $138.66 Million	CN¥125.36 Million ≈ $18.34 Million	0.132x	-7.97%
2021-12-31	CN¥807.21 Million ≈ $118.12 Million	CN¥116.04 Million ≈ $16.98 Million	0.144x	+14.65%
2020-12-31	CN¥735.66 Million ≈ $107.65 Million	CN¥92.24 Million ≈ $13.50 Million	0.125x	+24.61%
2019-12-31	CN¥674.71 Million ≈ $98.73 Million	CN¥67.89 Million ≈ $9.93 Million	0.101x	+31.36%
2018-12-31	CN¥611.60 Million ≈ $89.50 Million	CN¥46.85 Million ≈ $6.86 Million	0.077x	+49.58%
2017-12-31	CN¥555.58 Million ≈ $81.30 Million	CN¥28.45 Million ≈ $4.16 Million	0.051x	-72.92%
2016-12-31	CN¥327.82 Million ≈ $47.97 Million	CN¥61.99 Million ≈ $9.07 Million	0.189x	+34.49%
2015-12-31	CN¥288.89 Million ≈ $42.27 Million	CN¥40.62 Million ≈ $5.94 Million	0.141x	-28.71%
2014-12-31	CN¥246.19 Million ≈ $36.03 Million	CN¥48.56 Million ≈ $7.11 Million	0.197x	+63.50%
2013-12-31	CN¥210.84 Million ≈ $30.85 Million	CN¥25.43 Million ≈ $3.72 Million	0.121x	--

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic

Market Cap

$470.30 Million

CN¥3.21 Billion CNY

Market Cap Rank

#12840 Global

#4018 in China

Share Price

CN¥30.24

Change (1 day)

-0.23%

52-Week Range

CN¥26.92 - CN¥39.20

All Time High

CN¥74.44